US 11,890,270

Application 17/136,674 · Granted Feb 6, 2024

Polymorphic forms of st-246 and methods of preparation

Estimated expiration

August 8, 2032

5y 261d remaining

Confidence: medium
Medium: a terminal disclaimer was found but the patents it references could not be read, or several warnings were raised. Read the notes under the details.
Earliest effective filing
Mar 23, 2011
+ 20 years
Mar 23, 2031
PTA +504d
Aug 8, 2032
No TD
—
Final
Aug 8, 2032

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
December 29, 2020
Earliest effective filing
March 23, 2011
Issue date
February 6, 2024
PTA
+504 days
Base expiry (before PTA)
March 23, 2031

March 23, 2011 + 20 years = March 23, 2031 + 504 PTA days = August 8, 2032

  • Divisional of application 16/520,897, filed Jul 24, 2019, issued as US 10,933,050
  • Divisional of application 16/025,057, filed Jul 2, 2018, issued as US 10,406,137
  • Divisional of application 15/661,194, filed Jul 27, 2017, issued as US 10,045,964
  • Divisional of application 14/959,180, filed Dec 4, 2015, issued as US 9,744,154
  • Divisional of application 13/069,813, filed Mar 23, 2011, issued as US 9,339,466
  • Divisional of application 13/069,813, filed Mar 23, 2011, issued as US 9,339,466
  • Divisional of application 14/959,180, filed Dec 4, 2015, issued as US 9,744,154
  • Divisional of application 13/069,813, filed Mar 23, 2011, issued as US 9,339,466
  • Divisional of application 15/661,194, filed Jul 27, 2017, issued as US 10,045,964
  • Divisional of application 14/959,180, filed Dec 4, 2015, issued as US 9,744,154
  • Divisional of application 13/069,813, filed Mar 23, 2011, issued as US 9,339,466
  • Divisional of application 16/025,057, filed Jul 2, 2018, issued as US 10,406,137
  • Divisional of application 15/661,194, filed Jul 27, 2017, issued as US 10,045,964
  • Divisional of application 14/959,180, filed Dec 4, 2015, issued as US 9,744,154
  • Divisional of application 13/069,813, filed Mar 23, 2011, issued as US 9,339,466
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term
  • PRO61/316,747 — Provisional — not used for base term
  • PRO61/373,031 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/136,674 · US 11,890,270

PatentReply compiles the prosecution history behind US 11,890,270: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11890270

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.